These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
244 related items for PubMed ID: 16682280
1. Transitional cell bladder tumor: predicting recurrence and progression by analysis of microsatellite loss of heterozygosity in urine sediment and tumor tissue. Fornari D, Steven K, Hansen AB, Jepsen JV, Poulsen AL, Vibits H, Horn T. Cancer Genet Cytogenet; 2006 May; 167(1):15-9. PubMed ID: 16682280 [Abstract] [Full Text] [Related]
2. [Microsatellite instability in urine sediments from patients with transitional cell carcinoma of bladder and its clinical value]. Lü Y, Tang D, Yu L, Ding Y, Liu L, Guo Y. Zhonghua Wai Ke Za Zhi; 2000 Apr; 38(4):294-6. PubMed ID: 12828175 [Abstract] [Full Text] [Related]
5. Detection of loss of heterozygosity in the p53 tumor-suppressor gene with PCR in the urine of patients with bladder cancer. Friedrich MG, Erbersdobler A, Schwaibold H, Conrad S, Huland E, Huland H. J Urol; 2000 Mar; 163(3):1039-42. PubMed ID: 10688045 [Abstract] [Full Text] [Related]
8. TP53 alterations as a potential diagnostic marker in superficial bladder carcinoma and in patients serum, plasma and urine samples. Dahse R, Utting M, Werner W, Schimmel B, Claussen U, Junker K. Int J Oncol; 2002 Jan; 20(1):107-15. PubMed ID: 11743649 [Abstract] [Full Text] [Related]
9. Allelic deletion fingerprinting of urine cell sediments in bladder cancer. Larsson PC, Beheshti B, Sampson HA, Jewett MA, Shipman R. Mol Diagn; 2001 Sep; 6(3):181-8. PubMed ID: 11571711 [Abstract] [Full Text] [Related]
10. Non-invasive molecular detection of bladder cancer recurrence. Amira N, Mourah S, Rozet F, Teillac P, Fiet J, Aubin P, Cortesse A, Desgrandchamps F, Le Duc A, Cussenot O, Soliman H. Int J Cancer; 2002 Sep 20; 101(3):293-7. PubMed ID: 12209982 [Abstract] [Full Text] [Related]
16. Loss of heterozygosity on chromosomes 11 and 17 are markers of recurrence in TCC of the bladder. Edwards J, Duncan P, Going JJ, Grigor KM, Watters AD, Bartlett JM. Br J Cancer; 2001 Dec 14; 85(12):1894-9. PubMed ID: 11747332 [Abstract] [Full Text] [Related]
18. Loss of P16 expression and chromosome 9p21 LOH in predicting outcome of patients affected by superficial bladder cancer. Bartoletti R, Cai T, Nesi G, Roberta Girardi L, Baroni G, Dal Canto M. J Surg Res; 2007 Dec 14; 143(2):422-7. PubMed ID: 17612565 [Abstract] [Full Text] [Related]
19. Identification of loci associated with putative recurrence genes in transitional cell carcinoma of the urinary bladder. Edwards J, Duncan P, Going JJ, Watters AD, Grigor KM, Bartlett JM. J Pathol; 2002 Apr 14; 196(4):380-5. PubMed ID: 11920732 [Abstract] [Full Text] [Related]
20. Prognostic role of the tumor-associated tissue inflammatory reaction in transitional bladder cell carcinoma. Cai T, Nesi G, Boddi V, Mazzoli S, Dal Canto M, Bartoletti R. Oncol Rep; 2006 Aug 14; 16(2):329-34. PubMed ID: 16820911 [Abstract] [Full Text] [Related] Page: [Next] [New Search]